Ferring

E_DEPRECATED Error in file �functions_general.php� at line 326: Function utf8_encode() is deprecated

E_DEPRECATED Error in file �functions_general.php� at line 326: Function utf8_encode() is deprecated Ferring logo

E_DEPRECATED Error in file �functions_general.php� at line 186: Function utf8_encode() is deprecated

Headquartered in Saint-Prex, Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. A leader in reproductive and maternal health, Ferring has been developing treatments for mothers and babies for over 50 years. Today, over one third of the company’s research and development investment goes towards finding innovative treatments to help mothers and babies, from conception to birth. The company also identifies, develops and markets innovative products in the areas of urology, gastroenterology, endocrinology and orthopaedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.

Keywords:

Date	News
2020-02-04	Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX...
2020-01-23	Ferring’s Propess® is the first pharmacological treatment for cervical ripening to be approved in Japan for over 20 year...
2019-12-18	FerGene Appoints David Meek Chief Executive Officer
2019-12-05	FerGene announces pivotal Phase 3 study of nadofaragene firadenovec met its primary endpoint with more than half of pati...
2019-11-25	Ferring and Blackstone Life Sciences invest over $570 million USD in novel gene therapy for bladder cancer patients
2019-07-09	Heat-stable carbetocin has been added to the WHO Essential Medicines List for the prevention of excessive bleeding after...
2019-07-01	Ferring announces changes to Executive Committee
2019-06-19	Ferring collaboration with digital health innovators WOOM aims to help more people build families faster
2019-03-18	Ferring statement on subsidised pricing of heat-stable carbetocin for the prevention of postpartum haemorrhage in low- a...
2019-01-22	Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments

Date

News

2020-02-04

Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX...

2020-01-23

Ferring’s Propess® is the first pharmacological treatment for cervical ripening to be approved in Japan for over 20 year...

2019-12-18

FerGene Appoints David Meek Chief Executive Officer

2019-12-05

FerGene announces pivotal Phase 3 study of nadofaragene firadenovec met its primary endpoint with more than half of pati...

2019-11-25

Ferring and Blackstone Life Sciences invest over $570 million USD in novel gene therapy for bladder cancer patients